These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37753690)

  • 21. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel topical agent containing superoxide dismutase 100 000 IU and 4% of plant extracts as a mono-therapy for atopic dermatitis.
    Sgouros D; Katoulis A; Rigopoulos D
    J Cosmet Dermatol; 2018 Dec; 17(6):1069-1072. PubMed ID: 29134748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial.
    Ständer S; Kwatra SG; Silverberg JI; Simpson EL; Thyssen JP; Yosipovitch G; Zhang F; Cameron MC; Cella RR; Valdez H; DiBonaventura M; Feeney C
    Am J Clin Dermatol; 2023 Jan; 24(1):97-107. PubMed ID: 36512175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
    Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
    J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS
    Silverberg JI; Lai JS; Patel KR; Singam V; Vakharia PP; Chopra R; Sacotte R; Kantor R; Hsu DY; Cella D
    Br J Dermatol; 2020 Nov; 183(5):891-898. PubMed ID: 32107772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Immunomodulatory Treatments for Atopic Dermatitis: Update of a Living Systematic Review and Network Meta-analysis.
    Drucker AM; Morra DE; Prieto-Merino D; Ellis AG; Yiu ZZN; Rochwerg B; Di Giorgio S; Arents BWM; Burton T; Spuls PI; Schmitt J; Flohr C
    JAMA Dermatol; 2022 May; 158(5):523-532. PubMed ID: 35293977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial.
    Tsianakas A; Luger TA; Radin A
    Br J Dermatol; 2018 Feb; 178(2):406-414. PubMed ID: 28845523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis.
    Silverberg JI; Adam DN; Zirwas M; Kalia S; Gutermuth J; Pinter A; Pink AE; Chiricozzi A; Barbarot S; Mark T; Tindberg AM; Weidinger S
    Am J Clin Dermatol; 2022 Jul; 23(4):547-559. PubMed ID: 35857179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
    Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
    Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The improvement of infantile atopic dermatitis during the maintenance period: A multicenter, randomized, parallel controlled clinical study of emollients in Prinsepia utilis Royle.
    Wang S; Wang L; Li P; Shu H; Shen C; Wu Y; Luo Z; Miao L; Wang H; Jiao L; Tian J; Peng X; Zhao M; Liu Y; Nie X; He L; Ma L
    Dermatol Ther; 2020 Mar; 33(2):e13153. PubMed ID: 31705602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Instrumental evaluation of skin barrier function and clinical outcomes during dupilumab treatment for atopic dermatitis: An observational study.
    Cristaudo A; Pigliacelli F; Sperati F; Orsini D; Cameli N; Morrone A; Mariano M
    Skin Res Technol; 2021 Sep; 27(5):810-813. PubMed ID: 33651467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.
    Kamphuis E; Loman L; Han HL; Romeijn GLE; Politiek K; Schuttelaar MLA
    Contact Dermatitis; 2023 May; 88(5):351-362. PubMed ID: 36621910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis.
    Baron SE; Morris PK; Dye L; Fielding D; Goulden V
    Br J Dermatol; 2006 May; 154(5):942-9. PubMed ID: 16634899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients.
    Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Sacotte R; Patel KR; Singam V; Immaneni S; Kantor R; Hsu DY; Silverberg JI
    Ann Allergy Asthma Immunol; 2020 Mar; 124(3):261-266. PubMed ID: 31830585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dupilumab treatment induced similar improvements in signs, symptoms, and quality of life in adults with moderate-to-severe atopic dermatitis with baseline Eczema Area and Severity Index Score <24 or ≥24.
    Offidani A; Stingeni L; Neri I; Cipriani F; Chen Z; Rossi AB; Lu Y; Moretti D
    Ital J Dermatol Venerol; 2022 Feb; 157(1):39-46. PubMed ID: 33878856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, double-blind, split-side, comparison study of moisturizer containing licochalcone A and 1% hydrocortisone in the treatment of childhood atopic dermatitis.
    Wananukul S; Chatproedprai S; Chunharas A; Limpongsanuruk W; Singalavanija S; Nitiyarom R; Wisuthsarewong W
    J Med Assoc Thai; 2013 Sep; 96(9):1135-42. PubMed ID: 24163988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The benefit of a ceramide-linoleic acid-containing moisturizer as an adjunctive therapy for a set of xerotic dermatoses.
    Yang Q; Liu M; Li X; Zheng J
    Dermatol Ther; 2019 Jul; 32(4):e13017. PubMed ID: 31276265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study.
    Szczepanowska J; Reich A; Szepietowski JC
    Pediatr Allergy Immunol; 2008 Nov; 19(7):614-8. PubMed ID: 18208463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Lipid Foam Cream and Basic Cream on Epidermal Reconstruction in Mild Atopic Eczema.
    Dähnhardt D; Dähnhardt-Pfeiffer S; Schulte-Walter J; Hanisch E; Neubourg T; Fölster-Holst R
    Skin Pharmacol Physiol; 2022; 35(5):282-290. PubMed ID: 35705066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.